Minnesota Medical Development, Inc. Newsroom - Profile and News Archive

MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that it has been named as one of the ‘Top 50 Companies to Watch’ in the medical device industry by Medical Device and Diagnostic Industry (MD+DI) magazine. MMDI was chosen because of its ability to achieve success and also for its ability to manufacture products that have the potential to revolutionize care practices.

MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that it has been awarded an agreement under Novation’s ‘New Medical Technology’ program to supply its Rebound HRD and Rebound HRD V (hernia repair devices) to their alliance members, which includes: acute hospitals and systems, academic medical centers and ambulatory care facilities. The Rebound HRD® and HRD V are intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists.

MINNEAPOLIS, Minn., April 29 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD V (Hernia Repair Device). The Rebound HRD V is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.

MINNEAPOLIS, Minn., Nov. 19 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company’s BetaWire(TM) guidewire technology. The BetaWire(TM) is a super-torque interventional guidewire manufactured from a Beta Titanium alloy. Guidewires are thin, flexible wires that are used to facilitate the placement of balloon catheters and other diagnostic and therapeutic devices.

MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the Centers for Medicare & Medicaid Services (CMS) have agreed to create seven new ICD-9-CM reimbursement procedure codes for its new Rebound HRD (Hernia Repair Device). The new coding will become effective October 1, 2008. The Rebound HRD was recently FDA 510(k) cleared and is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects.

MINNEAPOLIS, Minn. – Aug. 21 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD(TM) (Hernia Repair Device). The Rebound HRD is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.